Cargando…
Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain
Around 20% of the American population have chronic pain and estimates in other Western countries report similar numbers. This represents a major challenge for global health care systems. Additional problems for the treatment of chronic and persistent pain are the comparably low efficacy of existing...
Autores principales: | Sisignano, Marco, Gribbon, Philip, Geisslinger, Gerd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899787/ https://www.ncbi.nlm.nih.gov/pubmed/35254645 http://dx.doi.org/10.1007/s40265-022-01689-0 |
Ejemplares similares
-
Auranofin: Repurposing an Old Drug for a Golden New Age
por: Roder, Christine, et al.
Publicado: (2015) -
SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain
por: Wedel, Saskia, et al.
Publicado: (2022) -
MicroRNA: Potential Targets for the Development of Novel Drugs?
por: Wu, Wei
Publicado: (2012) -
Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline
por: Mok, Chi Chiu
Publicado: (2023) -
Proton-Sensing GPCRs in Health and Disease
por: Sisignano, Marco, et al.
Publicado: (2021)